Waa maxay EnteraGam®?
EnteraGam® waa hab cusub oo loogu talagalay daaweynta shuban-biyoodka IBS (IBS-D). Waxaa Falanqeynaya FDA adoo ah raashin caafimaad oo rijeeto ah oo ay tahay inuu ku qoro dhakhtarkaaga ama bixiyaha daryeelka caafimaad ee kale ee liisan leh. Badeecadu waa budo ka kooban "" immunoglobulin ilmagaleenka "/ SBI" oo loo yaqaan "EnteraGam®".
Waxaad budada ku shubtaa dareeraha oo cabi kartaa.
SBI waxaa markii hore loogu talagalay in lagu taageero caafimaadka xiidmaha ee xayawaanka beeraha, laakiin dhawaanahan waxaa loo qiimeeyay daaweynta cudurka enteropathy (cudurrada mindhicirka) ee bini-aadanka, oo ay ka mid tahay in la xakameeyo saxarada aan caadiga ahayn ee IBS-D. Badeecadda waxaa laga soo saaraa lo'da waxayna ka kooban tahay qiyaastii 90% protein. Badeecadda looma nuugo heerka caloosha ama mindhicirka yar , si ay u sameyso habka ugu haboon ee mindhicirka weyn .Dhismida SBI ma ahan mid gebi ahaanba iska cad, laakiin cirridka lo'da ee lo'da ayaa laga yaabaa inay kor u qaadaan hawsha habboon ee habka GI . Bukaannada IBS waxay yeelan karaan jirro barar ah, taas oo aan weli si cad loo fahmin, sidaas darteed sababta shaqooyinka EnteraGam® maaha mid cad.
Waa maxay Cilmi-baaristu?
In kastoo ay jirto caddayn dheeraad ah oo SBI ku hagaajin karto daaweynta xayawaanka ee xayawaanka, tijaabooyinka tijaabada ah ee tijaabada ah ayaa tijaabiyay badeecada loo isticmaalo bini-aadanka, gaar ahaan dadka qaba enteropathy carruurta, kuwa qaba HIV , iyo dadka leh IBS-D.
Daraasad yar, laakiin la kala soocay, indho-indhayn, dijitobo, isticmaalka SBI ee IBS-D, ayaa muujisay in isticmaalka sheyga muddo lix toddobaad ah uu sababay hoos u dhac calaamadaha soo socda:
Wax saameyn ah lama arag, inkastoo maadooyin dhowr ah ay sababeen lallabo.
Natiijooyinkaa waa in la qaadaa taxaddar yar. Waxay ahayd daraasad yar, iyo bukaanada kooxda kantaroolka ahi waxay sidoo kale soo mareen xaalad calaamado ah, taas oo soo jeedineysa saameyn suurtagal ah oo suurtogal ah.
Daraasad kale ayaa lagu qiimeeyay ciladda sambabada tiro yar oo ka mid ah bukaannada IBS-D ama IBS-M kuwaas oo isticmaalay sheyga muddo lix toddobaad ah. Tani ma ahan daraasad laba-indho la ', daraasad lagu sameeyay. Horumarinta calaamadaha ayaa soo martay qiyaastii seddex meelood oo ka mid ah ka qaybgalayaasha daraasadda. Wax saameyn ah oo lama huraan ah lama hayo, inkastoo bukaanno yar ay joojiyeen isticmaalka sheyga sababtoo ah dhibaatooyinka soo raaca sida calool-galinta, shuban iyo lallabo.
Waxaan rajeyneynaa, cilmi-baaris mustaqbalka ah inay ku iftiimiso iftiin badan oo ku saabsan caawinta EnteraGam® oo ah doorasho daaweyn oo waxtar leh IBS-D.
Sidee Ayuu Caawin Karaa?
Iyada oo ku saleysan cilmi baarista ilaa taariikhda (xayawaanka iyo bini-aadanka) SBI waxaa loo maleynayaa inay suurtagal tahay:
- Bixinta manfacyada nafaqada.
- Isku qab qabasho sunta ku jirta.
- Yaraynta cyokokine gubanaya.
- Taageer habka difaaca jirka.
- Iska yaree iska durista mindhicirrada mindhicirka (xuubka xuubka xaamilada).
- Hagaajinta dheelitiridda qulqulka caloosha.
Ma Amaan tahay?
EnteraGam® waxaa lagu gartey FDA sida "Guud ahaan Aqoonsiga Amaan." Waa in aan loo isticmaalin dadka xasaasiyad ku leh hilibka lo'da. Wali lama qiimeynin amniga dumarka uurka leh ama kuwa kalkaaliyaha ah ama kuwa leh hab difaaca jirka.
Waxaa lagu baaray daraasado yaryar oo loogu talagalay isticmaalka carruurta yaryar iyo carruurta oo aan lahayn waxyeello halis ah oo la xusay.
Ma EnteraGam® Right for You?
Inkastoo cilmi baarista EnteraGam® ay ku jirto marxaladaha hordhaca ah, waxay hubaal ahaan u egyihiin balanqaadyo marka la eego ikhtiyaarka daaweynta ee amniga iyo suurtogalka ah ee IBS-D. Haddii calaamadahaagu aanay u jawaabin xeeladaha maareynta maareynta, waxaa laga yaabaa inaad rabto inaad la hadasho dhakhtarkaaga wixii ku saabsan tijaabada.
Ilaha:
Xayawaanku, B., et.al. "Qaybaha ka soo baxa borotiinka immunoglobulin ee loogu talagalay maaraynta nafaqada ee isbitaallada." Wargeyska Gastroenterology 2014 20: 11713-11726.
Xayawaanku, B., et.al. "Immunoglobulin suuf ah oo saafi ah / quudin nafaqo leh: habka loo dhajiyay qaabka loo maamulo maareynta daaweynta xanuunka" Gastroenterology Clinic and Exercision Gastroenterology 2014 7: 181-190.
Weinstock, J. & Jasion, V. "Serum-Derived Bovine Immunoglobulin / Protein Therapy Therapy for Patients with Refractory Syndrome-Sawirka Saxarada" " Journal Open Journal of Gastroenterology 2014 4: 5 pages.
Wilson, D., et.al. "Qiimeynta Serum-Dhib Buucinka Immunoglobulin Protein Iskuday Noocyada Shuban-Mukhaadaraadka Dhiigga Dareemidda Calaamadaha" Dareenka Caafimaadka Daaweynta: Gastroenterology 2013 6: 49-60.